Significance and Usefulness of Narrow Fragmented QRS Complex on 12-Lead Electrocardiogram in Acute ST-Segment Elevation Myocardial Infarction for Prediction of Early Mortality and Morbidity
2014; Wiley; Volume: 19; Issue: 4 Linguagem: Inglês
10.1111/anec.12133
ISSN1542-474X
AutoresBerna Stavılecı, Murat Çimci, Barış İkitimur, Hasan Ali Barman, Sevgi Özcan, Hayriye Esra Ataoğlu, Rasim Enar,
Tópico(s)Acute Myocardial Infarction Research
ResumoAnnals of Noninvasive ElectrocardiologyVolume 19, Issue 4 p. 338-344 ORIGINAL ARTICLEFree Access Significance and Usefulness of Narrow Fragmented QRS Complex on 12-Lead Electrocardiogram in Acute ST-Segment Elevation Myocardial Infarction for Prediction of Early Mortality and Morbidity Berna Stavileci M.D., Berna Stavileci M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorMurat Cimci M.D., Murat Cimci M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorBaris Ikitimur M.D., Corresponding Author Baris Ikitimur M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeyAddress for correspondence: Baris Ikitimur, M.D., Mahmutbey Cad. Avrupa Konutlari Atakent 2 Sitesi, B11 Blok D32 Halkali/Kucukcekmece, Istanbul. Fax: +90 212 5890808; E-mail: ikitimur@gmail.comSearch for more papers by this authorHasan Ali Barman M.D., Hasan Ali Barman M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorSevgi Ozcan M.D., Sevgi Ozcan M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorEsra Ataoglu M.D., Esra Ataoglu M.D. Department of Internal Medicine, Haseki Education and Research Hospital, Istanbul, TurkeySearch for more papers by this authorRasim Enar M.D., Rasim Enar M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this author Berna Stavileci M.D., Berna Stavileci M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorMurat Cimci M.D., Murat Cimci M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorBaris Ikitimur M.D., Corresponding Author Baris Ikitimur M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeyAddress for correspondence: Baris Ikitimur, M.D., Mahmutbey Cad. Avrupa Konutlari Atakent 2 Sitesi, B11 Blok D32 Halkali/Kucukcekmece, Istanbul. Fax: +90 212 5890808; E-mail: ikitimur@gmail.comSearch for more papers by this authorHasan Ali Barman M.D., Hasan Ali Barman M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorSevgi Ozcan M.D., Sevgi Ozcan M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this authorEsra Ataoglu M.D., Esra Ataoglu M.D. Department of Internal Medicine, Haseki Education and Research Hospital, Istanbul, TurkeySearch for more papers by this authorRasim Enar M.D., Rasim Enar M.D. Cerrahpasa School of Medicine, Department of Cardiology, Istanbul University, Istanbul, TurkeySearch for more papers by this author First published: 12 February 2014 https://doi.org/10.1111/anec.12133Citations: 22AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Abstract Background The presence of notched R or S waves without accompanying typical bundle branch blocks, or the existence of an additional wave like RSR' pattern in the original QRS complex (with a duration of 120 points (OR = 4.765), age >70 years (OR = 4.041), anterior MI localization (OR = 3.148), and presence of fQRS (OR = 2.484) were significant predictors of primary end points. fQRS increased the predictive ability of GRACE score >120 about two folds (OR = 7.305, P < 0.001). Conclusion Persistent fQRS on ECG is associated with poor prognosis and there is a lack of expected mortality benefit of RPT, particularly that of fibrinolytic therapy, in STEMI patients with fQRS. The presence of notched R or S waves without accompanying typical bundle branch block, or the existence of an additional wave like RSR' pattern in the original QRS complex (with a duration of 2 weeks.3, 4 The presence of fQRS has increased the diagnostic performance of ECG in the recognition of old MI, when added to Q wave analysis.1 The presence of fQRS without accompanying Q waves on ECG, has been able to diagnose ischemic heart disease (IHD) with a sensitivity of 62% and a specificity of 94%, and the existence of additional Q waves has increased the sensitivity of fQRS to 92.4%.5-8 The presence of fQRS in patients with IHD was demonstrated to be an independent predictor of decreased myocardial perfusion and functional deterioration, and a reflection of marked left ventricular (LV) dilatation and decreased ejection fraction (EF).9-11 fQRS has been recognized as a predictor of high mortality and recurrence of cardiac events, irrespective of the presence or absence of Q waves.12, 13 fQRS has been found to be associated with high mortality and arrhythmic events in coronary artery disease (CAD) and acute coronary syndromes (ACS). The presence of narrow (<120 ms) or wide (≥120 ms) fQRS complex on ECG of patients with known or suspected CAD, has been shown to demonstrate myocardial scarring.14 fQRS was also able to predict arrhythmic events in patients with ischemic or nonischemic cardiomyopathy.3, 15 The aim of this study was to investigate the prognostic significance of the persistence of the fragmentation of the original QRS complex (with a duration of <120 ms) found on the admission ECG in patients with acute ST segment elevation myocardial infarction (STEMI). The role of persistent fQRS in the prediction of early prognosis alone or in combination with established clinical risk scoring systems was also investigated. METHODS The study was carried out using retrospectively collected data of 296 consecutive patients diagnosed as acute STEMI and admitted to a university hospital between years 2007–2012. The study complies with the Declaration of Helsinki, and study protocol was approved by the local ethics committee. All patients had ST segment elevation of ≥2 mm in ≥2 contiguous precordial leads and/or ≥1 mm in ≥2 contiguous limb leads (II, III, aVF, and I, aVL). Patients with prior history of myocardial infarction, those with bundle branch blocks and/or evidence of prior myocardial infarction as depicted by Q waves in electrocardiograms prior to hospitalization for the index event were excluded from the study. The presence of notching in R or S waves or additional R waves in the original QRS complex (<120 ms) and without typical bundle branch block pattern in at least two contiguous leads related to a major coronary artery area was the definition used for fQRS. The presence of fQRS was also investigated using the last available in-hospital ECG and patients were divided into two groups as follows: fQRS group consisting of patients with persistent fQRS, that is, presence of fQRS both in admission and latest ECGs (n = 80, 27%), and non-fQRS group consisting of patients without persistent fQRS, that is, no fQRS in last ECG, irrespective of the initial ECG findings (n = 216, 73%). The following parameters were investigated: demographic characteristics, localization of MI, LV EF measured by transthoracic echocardiography (TTE) performed within the week of hospital discharge, drug therapy given in the first 24 hours after admission, duration of symptoms suggestive of myocardial ischemia at presentation, mode of reperfusion therapy, presence of successful reperfusion, in-hospital MI complications (hemodynamic and electrical instability), mortality, and coronary angiography findings in terms of number of vessels with ≥70% stenosis. Successful reperfusion was defined as ≥70% resolution of baseline ST segment elevation 90–120 minutes after the onset of thrombolytic therapy or restoration of TIMI-3 flow in infarct-related artery in patients undergoing primary percutaneous coronary intervention (PCI). Standard TTE was carried out using a System V echocardiography machine (GE, Vingmed Ultrasound AS, Horten, Norway). LV EF value was determined with Simpson's method of discs using 2-dimensional images. Primary end points were defined as in-hospital cardiovascular mortality, hemodynamic instability and electrical instability. Hemodynamic instability was defined as new onset acute heart failure or cardiogenic shock or hypotension (systolic blood pressure ≤95 mmHg) not due to vasodilator drugs and despite adequate fluid therapy. Electrical instability was defined as development of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) and atrioventricular (AV) block. GRACE and TIMI scores were calculated in order to evaluate the association between fQRS and risk factors predictive of study end points.16, 17 The predictive utility of persistent fQRS was investigated alone and when fQRS was added to models incorporating TIMI or GRACE scores. Statistical Analysis All statistical analyses were performed using SPSS version 16 (SPSS Inc., Chicago, IL, USA). A P value 0.05) was used to assess regression models. RESULTS The mean age of the study population was 60.98 ± 12.84 years and there were more males (76.4%). When the two groups were compared, there were no differences with respect to demographic characteristics except sex: number of female cases were significantly lower in the fQRS group (Table 1). The clinical, echocardiographic and angiographic characteristics of the patients are demonstrated (Table 2). There was no difference between the groups in terms of MI localization. When duration of chest pain was considered, 95.9% of the patients were admitted within 12 hours, and 91.2% were admitted within 8 hours of symptom onset. There was no difference between fQRS and non-fQRS groups with regard to the distribution of patients admitted with a chest pain duration of <8 hours. Table 1. Demographic Characteristics of the Patient Group Parameter fQRS Group (n = 80) Non-fQRS Group (n = 216) All Patients (n = 296) P Value Female sex (%) 12.5 27.8 23.6 0.006 Age (years) 60.90 ± 13.02 61.05 ± 12.89 60.98 ± 12.84 0.951 Diabetes mellitus (%) 35.0 22.2 25.7 0.114 Smoker (%) 65.0 62.0 62.8 0.74 Hypertension (%) 52.5 50.9 51.4 0.865 CAD (%) 22.5 22.2 22.3 0.971 CABG/PCI (%) 17.5 13.0 14.2 0.482 CAD = history of coronary artery disease; CABG/PCI = history of coronary artery bypass grafting or percutaneous coronary intervention; fQRS = narrow fragmented QRS complex on electrocardiogram. Table 2. Clinical Characteristics of the Patient Group Parameter fQRS Group (n = 80) Non-fQRS Group (n = 216) All Patients (n = 296) P Value Anterior MI (%) 60 55 56.41 0.44 Inferior MI (%) 35 42.12 40.2 0.26 RV MI (%) 5 2.77 3.37 0.34 LV EF (%) 37±11 44±13 42±13 0.003 LV EF < 35% (%) 45 20.8 27.36 0.00003 Three-vessel disease (%) 50 33.3 44.9 0.009 Symptom onset < 8 hours (%) 87.5 92.6 91.2 0.331 Symptom onset < 12 hours (%) 97.5 95.4 95.9 0.994 Acetylsalicylic acid* (%) 100 98.14 98.64 0.22 Clopidogrel* (%) 100 96.29 97.29 0.08 Beta-blocker* (%) 70 69.44 69.59 0.92 ACE-I* (%) 65 53.7 56.75 0.08 RPT (%) 97.5 93.05 94.25 0.14 Primary PCI (%) 30 34.72 33.44 0.44 Fibrinolytic therapy (%) 67.5 58.33 60.81 0.15 fQRS = narrow fragmented QRS complex on electrocardiogram; MI = myocardial infarction; RV = right ventricle; LV EF = left ventricular ejection fraction; ACE-I = angiotensin converting enzyme inhibitor; RPT = reperfusion therapy; PCI = percutaneous coronary intervention; (*) = drugs administered within 24 hours of infarction. No significant difference was found in terms of the standard medical therapy (aspirin, clopidogrel, beta-blockers, angiotensin converting enzyme [ACE] inhibitors) administered in the first day of admission (Table 2). Acute reperfusion therapy (RPT) was administered to 94.25% of the patients. Seventeen patients (2 in the fQRS, 15 in the non-fQRS group) did not receive RPT of any form. Fibrinolytic treatment was given to 60.81% of the cases (accelerated tPA in 98.8%, streptokinase only two patients) and primary PCI was utilized in the rest. There was no difference with regard to number of patients receiving RPT, and the RPT modality utilized. There was also no difference in terms of reperfusion success when fQRS and non-fQRS groups were compared (81.25% vs 87.12%) In 27.4% of the cases, LV EF was found to be <35% by TTE. The percentage of patients with EF values <35% was significantly higher in the fQRS group. The mean EF value of the fQRS group was also significantly lower compared to the non-fQRS group (Table 2). Coronary angiography was performed in 95% of the cases and three-vessel CAD was demonstrated in 44.9%. The frequency of three-vessel disease was significantly higher in the fQRS group, compared to the non-fQRS patients (Table 2). Overall in-hospital mortality was demonstrated to be 9.5%. All the end primary end points of the study, including mortality, hemodynamic instability, and electrical instability, were observed to be significantly more frequent in the fQRS group (Table 3). There were 34 cases with electrical instability (21 VT, 3 VF, 10 AV block [5 first degree, two 2:1, 3 complete]) in the fQRS group and 40 cases with electrical instability (19 VT, 7 VF, 14 AV block [12 first degree, 2 complete]) in the non-fQRS group. When AV blocks were omitted, there were still significantly more patients with electrical instability in the fQRS group (30% vs 12%, P = 0.0002). When patients with anterior MI were compared to patients with inferior MI, there were no differences in terms of mortality, hemodynamic instability and electrical instability (P = 0.20, P = 0.17, P = 0.61, respectively). Similar findings with regard to mortality, hemodynamic instability and electrical instability were noted when prognosis of anterior MI was compared to inferior MI in fQRS and non-fQRS groups (P = 0.79, P = 0.29, P = 0.12, respectively in the fQRS group and P = 0.12, P = 0.35, P = 0.50, respectively in the non-fQRS group). Table 3. Clinical End Points of the Study End Point fQRS Group (n = 80) Non-fQRS Group (n = 216) All Patients (n = 296) P Value Hemodynamic instability (%) 62.5 32.4 40.5 <0.001 Electrical instability (%) 42.5 18.5 25 <0.0001 Mortality (%) 20 5.5 9.5 <0.001 fQRS = narrow fragmented QRS complex on electrocardiogram. When mortality was evaluated in patients who had received any form of RPT, it was found to be significantly higher in patients with persistent fQRS, compared to the ones without persistent fQRS (Table 4). When mortality rate was investigated with respect to the utilized RPT method, it was found to be higher in the fQRS group among patients receiving FLT and also among patients undergoing primary PCI. Irrespective of the RPT modality utilized, mortality rate was higher in the fQRS group when only patients with successful reperfusion were considered (Table 4). Table 4. Reperfusion Therapy and Mortality Mortality (%) Reperfusion Therapy fQRS Group (n = 78) Non-fQRS Group (n = 201) P Value RPT 20.5 5.97 0.0002 Successful RPT 13.84 2.84 0.001 Unsuccessful RPT 53.84 28 0.11 FLT 25.9 9.52 0.004 Successful FLT 16.27 4.54 0.01 Unsuccessful FLT 63.63 43.75 0.3 PCI 8.33 0 0.01 fQRS = narrow fragmented QRS complex on electrocardiogram; RPT = mortality in patients who received reperfusion therapy; FLT = mortality in patients who received fibrinolytic treatment; PCI = mortality in whom primary percutaneous coronary intervention was performed (there were no unsuccessful percutaneous interventions). The frequency of persistent fQRS was found to be higher (71.4%) among patients who died (P < 0.001). The mean TIMI and GRACE risk scores were also significantly higher among patients who died, compared to the rest of the patient group (TIMI scores: 8.00 ± 2.59 vs 3.57 ± 2.2, P < 0.001 and GRACE scores: 136.68 ± 33.1 vs 207 ± 44.7, P < 0.001, respectively). There were significantly more patients with TIMI score >7 (66.7%) and GRACE score >120 (93.3%) in patients who had any primary end point (P < 0.001 in either case). In the regression model constructed from variables found to be related with occurrence of primary end points in the univariate analysis, GRACE score >120 points (OR = 4.765), age >70 years (OR = 4.041), anterior MI localization (OR = 3.148) and presence of fQRS (OR = 2.484) were demonstrated to be significant predictors of primary end points (Table 5). However, TIMI score >7 points, hospital admission 70 years 4.041 1477–11,058 0.007 GRACE score > 120 points 4.765 1922–11,813 0.001 fQRS = narrow fragmented QRS complex on electrocardiogram; MI = myocardial infarction. When the effect of the presence of fQRS in the constructed regression model on occurrence of primary end points was investigated, fQRS (OR = 2.617, P = 0.0029) increased the predictive ability of GRACE score >120 about two folds (OR = 7.305, P < 0.001). DISCUSSION In this study, the early prognostic significance of the presence of narrow ( 120, age >70 years, and anterior localization of MI, fQRS was able to increase the predictive ability of models constructed. Interestingly, administration of RPT, duration of MI symptoms at presentation and TIMI score >7 were not found to be independent predictors of end points, contrary to expectations. Possible reasons for this finding may include the inability of reported symptom onset in reflecting the actual onset of MI, the actual presentation delays of the patients to be more than self-reported durations, and late administration of RPT. The frequency of fQRS on ECG has been previously reported to be ranging from 34.9% to 60.1%, in patients with acute coronary syndrome.1, 2, 18 The presence of fQRS has been reported to predict mortality in CAD patients in general, and NSTE acute coronary syndrome patients in particular.13, 14, 18 fQRS has been demonstrated to form within about 24–48 hours of the symptom onset and persist thereafter, predicting cardiac events in CAD patients.4, 8, 19 In acute MI patients, it has been reported to independently predict low LV EF and infarct burden by cine magnetic resonance imaging, and in patients receiving RPT, no-reflow phenomenon.8, 19 The principal treatment strategies of STEMI, RPT rates and percentage of patients with reperfusion success did not significantly differ between fQRS and non-fQRS groups. However, although most of the patients (>90%) received timely RPT ( 120, TIMI score >7, increased rate of three-vessel CAD, were present significantly more frequent in the fQRS group; (b) in 2/3 of patients, FLT, which is recognized to be less efficacious, was used in the place of primary PCI; (c) mortality in fQRS patients receiving RPT was higher irrespective of the presence or absence of successful reperfusion. Although in >90% of the cases RPT was utilized, patients in the fQRS group had higher mortality irrespective of the RPT modality used or the treatment outcome. Probable explanations for this finding include: (a) three-vessel CAD was observed at a higher rate in the fQRS group, which may increase the area of myocardium at jeopardy; (b) occurrence of hemodynamic and electrical instability, which have been demonstrated to be associated with larger areas of ischemic and fibrotic myocardium characterized with its unstable nature in patients with acute coronary syndromes,1 was significantly more frequent in the fQRS group; (c) failure of RPT, especially in cases of FLT, may be associated with onset of acute infarction taking place before the onset of reported symptoms, as demonstrated in experimental studies related to fQRS.3, 20 fQRS well may be a sign of previous non-Q wave MI or transmural infarction without the development of Q waves;4, 21 (d) application of FLT as a RPT strategy in about 60% of the cases with fQRS may be associated with increased mortality because FLT has been reported to be less efficacious in acute MI with rather delayed presentation and hemodynamic compromise.22, 23 Presence of narrow fQRS on ECG of STEMI patients at admission may be a late electrophysiologic manifestation of a prior myocardial injury and/or scar rather than a new finding of index acute myocardial ischemia/infarction process, as generally considered. Narrow fQRS was found to be associated with larger infarcts and left ventricular dysfunction, which are indicative of increased mortality. The occurrence of narrow fQRS on ECG was found to be a significant predictor of malignant ventricular arrhythmias and hemodynamic compromise, as well as mortality, just like standard complex clinical risk scores like TIME and GRACE. Remarkable finding of our study is the close association of fQRS with poor prognosis, and the lack of expected mortality benefit of reperfusion therapy, particularly with FLT, in STEMI patients with fQRS. This was observed even in patients with successful clinical reperfusion, a finding which may be explained by possibility of late presentation and presence of severe hemodynamic disturbances. We suggest that in STEMI patients with fQRS who receive FLT as RPT, the assessment of reperfusion success by clinical means may be suboptimal, possibly due to the high rate of no-reflow or slow flow phenomenon (malperfusion). Thus, in patients with fQRS, intensive therapies directed at myocardial preservation and stabilization should be used along with primary PCI, and keeping high probability three-vessel in mind, mechanical support and hybrid reperfusion strategies with coronary bypass grafting should be utilized in unstable patients as needed. Limitations RPT was administered only to 94.25% of the patients enrolled in the study. Although there was no difference with regard to number of patients receiving RPT, RPT modality utilized and RPT success between fQRS and non-fQRS groups, presence of patients with no RPT may be considered as a limitation during the interpretation of our findings. REFERENCES 1Das KM, Khan B, Jacob S, et al. Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation 2006; 113: 2495– 2501. CrossrefPubMedWeb of Science®Google Scholar 2Guo R, Li Y, Xu Y, et al. Significance of fragmented QRS complexes for identifying culprit lesions in patients with non-ST-elevation myocardial infarction: a single-center, retrospective analysis of 183 cases. BMC Cardiovascular Disorders 2012; 12: 44. doi:10.1186/1471-2261-12-44. CrossrefPubMedWeb of Science®Google Scholar 3Jose F, Krishman M. Fragmanted QRS electrocardiogram-the hidden talisman? Indian Pacing Electrophysiol J 2009;(5): 238– 240. Google Scholar 4Yasuda M, Lida H, Itagane H, et al. Significance of Q wave disappearance in the chronic phase following transmural acute myocardial infarction. Jpn Circ J 1990; 54: 1517– 1524. CrossrefCASPubMedWeb of Science®Google Scholar 5Gardner PI, Ursell PC, Fenoglio JJ Jr, et al. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation 1985; 72: 596– 611. CrossrefCASPubMedWeb of Science®Google Scholar 6France RJ, Formolo JM, Penney DG. Value of notching and slurring of the resting QRS complex in the detection of ischemic heart disease. Clin Cardiol 1990; 13: 190– 196. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 7Yan AT, Tan M, Fitchett D, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 2004; 94: 25– 29. CrossrefPubMedWeb of Science®Google Scholar 8Yang H, Pu M, Rodriguez D, et al. Ischemic and viable myocardium in patients with non–Q-wave or Q-wave myocardial infarction and left ventricular dysfunction: a clinical study using positron emission tomography, echocardiography, and electrocardiography. J Am Coll Cardiol 2004; 43: 592– 598. CrossrefPubMedWeb of Science®Google Scholar 9Michael MA, El Masry H, Khan BR, et al. Electrocardiographic signs of remote myocardial infarction. Prog Cardiovasc Dis 2007; 50: 198– 208. CrossrefPubMedWeb of Science®Google Scholar 10Mahenthiran J, Khan BR, Sawada SG, et al. Fragmented QRS complexes not typical of a bundle branch block: a marker of greater myocardial perfusion tomography abnormalities in coronary artery disease. J Nucl Cardiol 2007; 14: 347– 353. CrossrefPubMedWeb of Science®Google Scholar 11Flowers NC, Horan LG, Thomas JR, et al. The anatomic basis for high-frequency components in the electrocardiogram. Circulation 1969; 39: 531– 539. CrossrefCASPubMedWeb of Science®Google Scholar 12Nabil El-Sherif. The rsR' pattern in left surface leads in ventricular aneurysm. Br Heart J 1970; 32: 440– 448. CrossrefPubMedGoogle Scholar 13Pietrasik G, Goldenberg I, Zdzienicka J, et al. Prognostic significance of fragmented QRS complex for predicting the risk of recurrent cardiac events in patients with Q-wave myocardial infarction. Am J Cardiol 2007; 100: 583– 586. CrossrefPubMedWeb of Science®Google Scholar 14Das MK, Saha C, El Masry H, et al. Fragmented QRS on a 12-lead ECG: a predictor of mortality and cardiac events in patients with coronary artery disease. Heart Rhythm 2007; 4: 1385– 1392. CrossrefPubMedWeb of Science®Google Scholar 15Das MK, Zipes DP. Role of the fragmented QRS complexes on a routine 12-lead ECG in predicting mortality and sudden cardiac death. Rev Argent Cardiol 2010; 5– 10. CASGoogle Scholar 16Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031– 2037. CrossrefCASPubMedWeb of Science®Google Scholar 17Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333: 1091– 1094. CrossrefPubMedWeb of Science®Google Scholar 18Das MK, Michael MA, Suradi H, et al. Usefulness of fragmented QRS on a 12-Lead electrocardiogram in acute coronary syndrome for predicting mortality. Am J Cardiol 2009; 104: 1631– 1637 CrossrefPubMedWeb of Science®Google Scholar 19Abdulla J, Brendorp B, Torp-Pedersen C, et al. Does the electrocardiographic presence of Q waves influence the survival of patients with acute myocardial infarction? Eur Heart J 2001; 22: 1008– 1014. CrossrefCASPubMedWeb of Science®Google Scholar 20Chatterjee S, Changawala N. Fragmented QRS complex: a novel marker of cardiovascular disease. Clin Cardiol 2010; 33(2): 68– 71. Wiley Online LibraryWeb of Science®Google Scholar 21Voon WC, Chen YW, Hsu CC, et al. Q-wave regression after acute myocardial infarction assessed by Tl-201 myocardial perfusion SPECT. J Nucl Cardiol 2004; 11: 165– 170. CrossrefPubMedWeb of Science®Google Scholar 22 Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311– 322. CrossrefPubMedWeb of Science®Google Scholar 23Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999; 341: 625– 634. CrossrefCASPubMedWeb of Science®Google Scholar Citing Literature Volume19, Issue4July 2014Pages 338-344 This article also appears in:Annals of Noninvasive Electrocardiology ReferencesRelatedInformation
Referência(s)